Guillain-Barré-like syndrome associated with lung adenocarcinoma and CASPR2 antibodies

Muscle and Nerve

Volumn 48, Issue 5, 2013, Pages 836-837

  Tüzün, Erdem ^a   Kinay, Demet ^b   Hacohen, Yael ^c   Aysal, Fikret ^b   Vincent, Angela ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Bakirkoy Training and Research Hospital for Psychiatry   (Turkey)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; VOLTAGE GATED POTASSIUM CHANNEL;

ACTION POTENTIAL; ADULT; ANTIBODY SCREENING; CASE REPORT; FATIGUE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOREACTIVITY; LETTER; LIMB WEAKNESS; LUNG ADENOCARCINOMA; MALE; MOTOR UNIT POTENTIAL; MUSCLE STRENGTH; MYOKYMIA; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; SENSORIMOTOR NEUROPATHY; SMOKING; TENDON REFLEX; TRANSTHORACIC ASPIRATION; WEIGHT REDUCTION; WHOLE BODY CT;

ADENOCARCINOMA; ADULT; AUTOANTIBODIES; GUILLAIN-BARRE SYNDROME; HEK293 CELLS; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS;

EID: 84886748192     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23851     Document Type: Letter

References (10)

1. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012;366:2294-2304.
2. Rosen BA. Guillain-Barré syndrome. Pediatr Rev 2012;33:164-170.
3. Antoine JC, Mosnier JF, Absi L, Convers P, Honnorat J, Michel D. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J Neurol Neurosurg Psychiatry 1999;67:7-14.
4. Lagrange E, Veran O, Besson G. Pure motor relapsing Guillain-Barré syndrome associated with anti-GM1 antibodies revealing urinary bladder cancer. Eur J Neurol 2007;14:e7.
5. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-1140.
6. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734-2748.
7. Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 2012;72:241-255.
8. Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 1997;41:238-246.
9. Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, Martinez-Hernandez E, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011;69:303-311.
10. Tüzün E, Kürtüncü M, Lang B, Icöz S, Akman-Demir G, Eraksoy M, et al. Bickerstaff's encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies. Eur J Neurol 2010;17:1304-1307.